Phase 1 Pemphigus Vulgaris Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
Pemphigus Vulgaris
Cabaletta Bio40 enrolled13 locationsNCT04422912
Recruiting
Phase 1
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
Rheumatoid ArthritisPemphigus VulgarisSystemic Lupus Erythematosus+1 more
IRIS Research and Development, LLC30 enrolled1 locationNCT06581562
Completed
Phase 1
A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008
Rheumatoid ArthritisPemphigus Vulgaris
Principia Biopharma Australia Pty Ltd14 enrolled1 locationACTRN12616001557426